Exhibit 99.1

	Dr. Reddy's Laboratories Ltd.
	8-2-337, Road No. 3, Banjara Hills,
	Hyderabad - 500 034, Telangana,
	India.
	CIN: L85195TG1984PLC004507
	Tel      : +91 40 4900 2900
	Fax     : +91 40 4900 2999
	Email : mail@drreddys.com
	www.drreddys.com

January 15, 2019

Corporate Relationship Department	National Stock Exchange of India Ltd.
BSE Limited	“Exchange Plaza”
Dalal Street, Fort	Bandra-Kurla Complex, Bandra (East),
Mumbai – 400 001	Mumbai – 400 051
Fax Nos.: 022-22723121 / 22723719 /	Fax Nos.: 022-26598120/ 26598237/
22722037 / 22722039	26598238

Scrip Code: 500124 Scrip Code: DRREDDY-EQ

Dear Sirs,

Sub: Intimation

This is to inform you that the audit of our Formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the US FDA, has been completed today. We have been issued a Form 483 with 4 (four) observations, which we are addressing.

This is for your information.

With regards,

 

Vikas Sabharwal

Assistant Company Secretary

CC:- New York Stock Exchange Inc.(Stock Code :RDY)